Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Pfizer Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Pfizer Inc. (NYSE:PFE) is scheduled to release its financial results for the second quarter, before the opening bell on Tuesday.
辉瑞公司（纽交所：PFE）定于周二开盘前公布其第二季度财报。
Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, down from 67 cents per share in the year-ago period. Pfizer expects to post revenue of $13.02 billion, compared to $12.73 billion a year earlier, according to data from Benzinga Pro.
据Benzinga Pro的数据显示，分析师预计这家总部位于纽约的公司将报告每股46美分的季度收益，低于去年同期的每股67美分。辉瑞公司预计营业收入为130.2亿美元，而去年同期为127.3亿美元。
On July 25, Pfizer announced that the European Commission approved a conditional marketing authorization for DURVEQTIX, a gene therapy for severe and moderately severe hemophilia B in adults whom meet certain criteria.
7月25日，辉瑞宣布，欧洲委员会批准了DUR-VEQTTM的有条件的市场授权，该基因治疗用于符合某些标准的成年严重和中度严重的血友病B患者。
Pfizer shares fell 0.2% to close at $30.72 on Monday.
周一，辉瑞股价下跌0.2％，收于30.72美元。
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Benzinga的读者可以在分析师股票评级页面上获取最新的分析师评级。读者可以按股票代号、公司名称、分析师公司、评级变化或其他变量排序。
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
让我们来看看Benzinga最准确的分析师是如何评价公司的。
- Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $45 on July 10. This analyst has an accuracy rate of 69%.
- Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and raised the price target from $28 to $29 on May 2. This analyst has an accuracy rate of 71%.
- BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and boosted the price target from $33 to $36 on May 2. This analyst has an accuracy rate of 71%.
- Argus Research analyst David Toung downgraded the stock from Buy to Hold on March 22. This analyst has an accuracy rate of 68%.
- Guggenheim analyst Vamil Divan initiated coverage on the stock with a Buy rating and a price target of $36 on Feb. 23. This analyst has an accuracy rate of 76%.
- Cantor Fitzgerald的分析师Louise Chen在7月10日重申了对该股票的增持评级，目标价格为45美元。该分析师的准确率为69％。
- 摩根士丹利的分析师Terence Flynn于5月2日维持了等权重的评级，并将目标价格从28美元上调至29美元。该分析师的准确率为71％。
- BMO Capital的分析师Evan David Seigerman于5月2日重申跑赢大盘的评级，并将目标价格从33美元上调至36美元。该分析师的准确率为71％。
- 雅运股份的分析师大卫·汤（David Toung）于3月22日将股票评级从买入下调至持有。该分析师的准确率为68%。
- 古根海姆的分析师Vamil Divan于2月23日开始对该股票进行覆盖，评级为买入，目标价格为36美元。该分析师的准确率为76％。
Read This Next:
阅读以下内容：
- More Than $4M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying
- 投资超过400万美元的人赌appian？看看这3支股票内部人士正在购买